Abbott Laboratories Total Debt 2007–2025
Abbott Laboratories reported $12.93B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 8.5% lower than fiscal 2024. Compared with fiscal 2020, the change was -31.0%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $12.93B | -8.5% |
| FY 2024 | $14.13B | -3.8% |
| FY 2023 | $14.68B | -12.5% |
| FY 2022 | $16.77B | -7.1% |
| FY 2021 | $18.05B | -3.7% |
| FY 2020 | $18.75B | +3.4% |
| FY 2019 | $18.14B | -7.3% |
| FY 2018 | $19.57B | -29.9% |
| FY 2017 | $27.92B | +26.9% |
| FY 2016 | $22.01B | +144.5% |
| FY 2015 | $9.00B | +15.0% |
| FY 2014 | $7.83B | +19.3% |
| FY 2013 | $6.56B | -68.0% |
| FY 2012 | $20.48B | +32.8% |
| FY 2011 | $15.41B | -18.5% |
| FY 2010 | $18.92B | +15.0% |
| FY 2009 | $16.46B | +43.8% |
| FY 2008 | $11.45B | +1.1% |
| FY 2007 | $11.32B | — |
Source: Abbott Laboratories SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ABT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Abbott Laboratories reported $12.93B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 8.5% lower than fiscal 2024. Compared with fiscal 2020, the change was -31.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Abbott Laboratories
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbott Laboratories — frequently asked questions
What is Abbott Laboratories's total debt (short- plus long-term borrowings)?
Abbott Laboratories (ABT) reported total debt (short- plus long-term borrowings) of $12.93B for fiscal year 2025, per its SEC filings.
How has Abbott Laboratories's total debt (short- plus long-term borrowings) changed over time?
Between fiscal 2007 and 2025, ABT's total debt (short- plus long-term borrowings) grew at roughly 0.7% per year (compound annual rate), from $11.32B to $12.93B.
Where does this data come from?
Figures are computed from Abbott Laboratories's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.
More ABT financial history
Full ABT fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →